After Neuralink, Max Hodak is building something stranger

Max Hodak, co-founder and former president of Neuralink, has launched a new venture called Science Corp., aiming to push the boundaries of brain-computer interface (BCI) technology beyond what Neuralink achieved. Drawing on his experience working closely with Elon Musk, Hodak emphasizes innovative engineering breakthroughs—such as creating fully implantable, low-power devices that minimize infection risks—rather than new neuroscience discoveries, which have been ongoing for decades. Science Corp. differentiates itself by generating revenue early through selling affordable research tools and developing a near-term commercial product, rather than relying solely on fundraising. The company’s flagship product, Prima, is a retinal implant smaller than a grain of rice designed to restore “form vision” to people with advanced macular degeneration. Combined with camera-equipped glasses and a portable battery, Prima offers a significant improvement over previous vision restoration technologies. Hodak envisions this as a stepping stone toward more ambitious goals of enhancing human cognition and consciousness through BCI technology. Meanwhile, global interest